| Literature DB >> 10562709 |
Abstract
Membrane-bound complement regulatory proteins (mCRPs) play an important role in the protection of cells from complement-mediated injury. It is now apparent that malignant tumor cells also express these proteins to escape complement attack. Here, Arko Gorter and Seppo Meri discuss the implications of complement resistance for the immunotherapeutic treatment of solid tumors with monoclonal antibodies.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10562709 DOI: 10.1016/s0167-5699(99)01537-6
Source DB: PubMed Journal: Immunol Today ISSN: 0167-5699